Medtronic (NYSE: MDT) today announced a new interim analysis evaluating automated sacral neuromodulation (SNM) therapy.

GE HealthCare Q1 results beat the Wall Street analyst consensus — but it lowered its full-year EPS guidance due to tariff impacts.

Teleflex (NYSE: TFX) announced that it received FDA 510(k) clearance for expanded indications of its QuikClot Control+ hemostatic device.

Chipiron announced today that it raised $17 million in a funding round to complete the development of its miniaturized MRI ...

Cad (Nasdaq:ICAD) announced today that it entered into a collaboration with Microsoft to advance AI-powered mammography ...

HistoSonics today announced 12-month follow-up clinical data from its prospective HOPE4LIVER trials evaluating its ...

HeartBeam (Nasdaq:BEAT) today announced that a study of its synthesized 12-lead electrocardiogram (ECG) met its clinical ...

Orchestra BioMed (Nasdaq:OBIO) announced that it received FDA investigational device exemption (IDE) for its Virtue ...

Kestra Medical Technologies today announced the presentation of new real-world data for its Assure wearable cardioverter ...

Sonavex announced that it received FDA 510 (k) clearance for its AI-enabled EchoMap device with 3D ultrasound capabilities.